PROFECTUS BIOSCIENCES
Profectus Biosciences is a research and development company dedicated to harnessing the immune system to treat and prevent viral diseases and cancers through the delivery of our proprietary prime/boost vaccines and small molecules.
PROFECTUS BIOSCIENCES
Social Links:
Industry:
Biotechnology Electronic Health Record (EHR) Health Care Health Diagnostics
Founded:
2002-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.profectusbiosciences.com
Total Employee:
11+
Status:
Active
Contact:
4106335709
Email Addresses:
[email protected]
Total Funding:
34.67 M USD
Technology used in webpage:
Domain Not Resolving SPF Google Maps Microsoft Exchange Online Office 365 Mail GStatic Google Static Content Google Maps API Unified Layer HostMonster DNS
Similar Organizations
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Cross Atlantic Capital Partners
Cross Atlantic Capital Partners investment in Venture Round - Profectus Biosciences
Cross Atlantic Capital Partners
Cross Atlantic Capital Partners investment in Venture Round - Profectus Biosciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-09 | The University of Texas Medical Branch | Profectus Biosciences investment in Grant - The University of Texas Medical Branch | 35 M USD |
Official Site Inspections
http://www.profectusbiosciences.com
- Host name: 74-220-203-200.unifiedlayer.com
- IP address: 74.220.203.200
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Profectus Biosciences"
Profectus Biosciences - Crunchbase Company Profile & Funding
Profectus Biosciences is a research and development company dedicated to harnessing the immune system to treat and prevent viral diseases and cancers through the delivery of our โฆSee details»
Profectus BioSciences, Inc - LinkedIn
Profectus BioSciences, Inc | 580 followers on LinkedIn. Profectus BioSciences is an innovative clinical stage vaccine company devoted to preventing and treating viral diseases and malaria through ...See details»
Profectus Biosciences, Inc. Company Profile | Pearl River, NY ...
Find company research, competitor information, contact details & financial data for Profectus Biosciences, Inc. of Pearl River, NY. Get the latest business insights from Dun & Bradstreet.See details»
Profectus Biosciences - The Org
Profectus Biosciences is a R&D company developing vaccine and small molecules to treat and prevent viral diseases and cancers. Industries. Biotechnology, Health Care +2. Headquarters. โฆSee details»
Profectus Biosciences (PBS) - Devex
Learn more about Profectus Biosciences (PBS)'s jobs, projects, latest news, contact information and geographical presence. ... Type of organization. Development Consulting Service โฆSee details»
Profectus BioSciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Profectus BioSciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 32 literature, Disease Domain:Infectious Diseases, Technology โฆSee details»
Profectus BioSciences - PitchBook
Profectus BioSciences General Information Description. Developer of preventive, therapeutic, and oncolytic vaccines designed to treat and prevent viral diseases. The company's vaccines are used for infectious diseases and cancer โฆSee details»
Profectus BioSciences Company Profile | Management and
Profectus BioSciences Profile and History. About Profectus Biosciences, Inc.: Profectus BioSciences, Inc. is a clinical-stage vaccine platform company developing novel vaccines for โฆSee details»
Profectus Biosciences Inc - Company Profile and News
Profectus Biosciences, Inc. develops vaccines. The Company offers vaccine products to address diseases caused by hepatitis C, human immunodeficiency, human papilloma, and herpes โฆSee details»
Profectus Biosciences, Inc. - Baltimore , MD - Company Profile
Profectus Biosciences, Inc. CLAIM THIS BUSINESS. 6411 BECKLEY ST STE 201 BALTIMORE, MD 21224 Get Directions (443) 743-1100. www.profectusbiosciences.com . Business Info. โฆSee details»
Profectus BioSciences - Craft
Profectus BioSciences is a company that provides vaccines for infectious diseases and cancer immunotherapy. It uses a proprietary technology platform for the development of vaccines โฆSee details»
Profectus BioSciences - VentureRadar
Profectus BioSciences, Inc. identifies and commercializes technologies intended to reduce the morbidity and mortality caused by viral diseases, especially Human Immunodeficiency Virus โฆSee details»
Aurobindo Pharma Acquires Certain Assets of Profectus โฆ
Aurobindo Pharma USA, Inc., finalized the asset acquisition transaction with Profectus BioSciences Inc. This new subsidiary is called Auro Vaccines LLC. Profectus BioSciences Inc. โฆSee details»
Profectus Biosciences: Revenue, Worth, Valuation & Competitors โฆ
About Profectus Biosciences. Profectus Biosciences is a Biotech related company founded in 2005 and based in Baltimore with an estimated revenue of $1.2M, and 16 employees. It has โฆSee details»
Profectus BioSciences, Inc. Names New CEO - BioSpace
Jan 28, 2008 He comes to Profectus BioSciences from Solstice Neurosciences Inc., where he served as president and chief executive officer since 2004. During his tenure at Solstice, โฆSee details»
Profectus BioSciences - Products, Competitors, Financials, โฆ
Headquarters Location. 6411 Beckley Street Suite N201. Baltimore, Maryland, 21224, United States. 443-743-1100See details»
Nextsource | Company Profile | Profectus Biosciences
Monitor if Profectus Biosciences is shifting their marketing strategy based on recent ad campaigns or rebranding efforts. Discover if Profectus Biosciences is expanding into new markets or โฆSee details»
CEPI Awards Contract Worth up to $36 million to Profectus โฆ
CEPI (the Coalition for Epidemic Preparedness Innovations) today announced a new collaboration with Profectus BioSciences, Inc. and Emergent BioSolutions Inc. (NYSE: EBS) under which โฆSee details»
Profectus, Emergent BioSolutions and PATH join forces in search โฆ
May 25, 2018 The global alliance plans to grant up to $25 million over the next five years to Profectus BioSciences and Emergent BioSolutions, which are working on a candidate to โฆSee details»
Profectus BioSciences, Inc. (Profectus BioSciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
ไบ่งฃProfectus BioSciences, Inc. (Profectus BioSciences, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1็ฏๆฐ้ปๅ32็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:ๆๆ๏ผๆๆฏๅนณๅฐ:้็ป่ฝฝไฝ็ซ่๏ผ้ข้ฒๆง็ซ่๏ผ โฆSee details»